Sec Form 3 Filing - E&Investment, Inc. @ NeuroBo Pharmaceuticals, Inc. - 2019-12-30

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person E&Investment, Inc. 2. Issuer Name and Ticker or Trading Symbol NeuroBo Pharmaceuticals, Inc. [ NRBO] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) C/O NEUROBO PHARMACEUTICALS, INC, 177 HUNTINGTON AVENUE, SUITE 1700 3. Date of Earliest Transaction (MM/DD/YY) 12/30/2019 (Street) BOSTON, MA02115 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 4,335,800 I Held by The E&Healthcare Investment Fund II ( 1 ) ( 4 ) Common Stock 1,121,190 I Held by The E&Healthcare Investment Fund No. 6 ( 2 ) ( 4 ) Common Stock 1,864,799 I Held by The E&Healthcare Investment Fund No. 7 ( 3 ) ( 4 )

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other E&Investment, Inc. C/O NEUROBO PHARMACEUTICALS, INC 177 HUNTINGTON AVENUE, SUITE 1700 BOSTON, MA02115 X Signatures /s/ E&Investment,Inc., By: Na Yeon Kim, CEO 01/09/2020 Signature of Reporting Person Date

Explanation of Responses:

( 1 )These shares are owned directly by The E&Healthcare Investment Fund II, a 10% owner of the Issuer, and indirectly by E&Investment, Inc., as sole general partner of The E&Healthcare Investment Fund II. ( 2 )These shares are owned directly by The E&Healthcare Investment Fund No. 6, and indirectly by E&Investment, Inc., as sole general partner of The E&Healthcare Investment Fund No. 6 ( 3 )These shares are owned directly by The E&Healthcare Investment Fund No.7, a 10% owner of the Issuer, and indirectly by E&Investment, Inc., as sole general partner of The E&Healthcare Investment Fund No.7. ( 4 )E&Investment, Inc. disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.

Remarks: Exhibit 24 - Power of Attorney

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.